Stamford, CT -- (SBWIRE) -- 03/01/2013 -- Jet Life Penny Stocks provides investors with the Best penny stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletters and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Zogenix, Inc.(NASDAQ:ZGNX) surged +10.00% with the closing price of $1.87, extending rally on improved investor hopes of U.S. regulatory approval. The Food and Drug Administration disclosed earlier this weekthat it won’t be able to meet a March 1 deadline to decide whether to approve the painkiller, called Zohydro, because more time is needed to review data, according to a statement from San Diego-based Zogenix. Two rating firms, Leerink Swann & Co. and Wells Fargo Securities LLC, suggested the delay means the drug likely will be approved.
What ZGNX’s Charts Are Signaling for Traders? Find Out Here
The overall volume in the last trading session was 9.45 million shares. Its fifty two week range was $1.11-$3.30. The total market capitalization remained $188.25million.The stock is ahead its 52 week low with 68.47% and its last month price volatility remained 8.77% with a target price of $3.00. In its share capital, the company has 100.67 million outstanding shares while 99.54 million shares have been floated in market.
It has insider ownership of 0.51% with its institutional ownership remained 73.62%. Its current year earnings per share grew with 88.86%.
Orexigen Therapeutics, Inc.(NASDAQ:OREX) shares went 9.78% up and closed at $5.95 in the last trading session after saying that management is scheduled present a company overview at the Cowen & Co. Annual Health Care Conference in Bostonplanned forMonday, March 4, 2013 at 3:30 p.m. Eastern Time. Its overall traded volume was 2.23 million shares. The stock’s opening price was $5.42, hitting the day high price of $5.99 and day low of $5.37.
Should OREX a Buy or Sell Now? Find Out Here
OREX has earnings per share of -$0.93. The company has -70.38% returns on assets, -190.25% returns on equity and its return on investments is -83.78%.
Herbalife Ltd.(NYSE:HLF) jumped +7.61% to close at $40.29 and its total volume in the last trading session was 10.46 million shares after taking decision to add two of billionaire investor Carl Icahn's nominees to its board. In last 52 weeks, high hit was $73.00 and low price in that period was $24.24.
Can HLF Show a Strong Recovery? Find out in This Research Report
The company has outstanding shares of 103.09million with the total market cap of $4.15 billion and its beta value stands at 1.69 times. It has current ratio of 1.34 and its debt-to-equity ratio is 1.16.
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)